U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 07:26:31 GMT 2025
Edited
by admin
on Wed Apr 02 07:26:31 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
0SOY20O318
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Zaltenibart
INN   USAN  
Official Name English
OMS-906
Preferred Name English
H-gamma4 heavy chain (1-440) [VH Musmus/Homsap (Mus musculus IGHV1-9*01 (79.6%) -(IGHD) -IGHJ3*01 (90.9%) A128>S (113)/Homo sapiens IGHV1-46*01 (79.6%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [8.8.6] (26-33.51-58.97-102)) (1-113)-Homo sapiens IGHG4*01, nG4m(a
Common Name English
RECOMBINANT HUMANISED IgG4 KAPPA ANTI-(MASP 3) DISULFIDE MONOCLONAL ANTIBODY OMS906
Common Name English
Humanized immunoglobulin G4 monoclonal antibody directed against mannan-binding lectin-associated serine protease-3 (MASP-3)
Common Name English
Immunoglobulin G4 [221-proline,421-leucine,427-serine], anti-(human serine proteinase MASP3) (human-Mus musculus monoclonal OMS906 ?4-chain), disulfide with human-Mus musculus monoclonal OMS906 ?-chain, dimer
Common Name English
zaltenibart [INN]
Common Name English
ZALTENIBART [USAN]
Common Name English
immunoglobulin G4-kappa, anti-[Homo sapiens MASP3 (mannan-binding lectin-associated serine protease-3)]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 830121
Created by admin on Wed Apr 02 07:26:31 GMT 2025 , Edited by admin on Wed Apr 02 07:26:31 GMT 2025
Code System Code Type Description
INN
12858
Created by admin on Wed Apr 02 07:26:31 GMT 2025 , Edited by admin on Wed Apr 02 07:26:31 GMT 2025
PRIMARY
SMS_ID
300000023259
Created by admin on Wed Apr 02 07:26:31 GMT 2025 , Edited by admin on Wed Apr 02 07:26:31 GMT 2025
PRIMARY
CAS
2527079-60-1
Created by admin on Wed Apr 02 07:26:31 GMT 2025 , Edited by admin on Wed Apr 02 07:26:31 GMT 2025
PRIMARY
USAN
MN-81
Created by admin on Wed Apr 02 07:26:31 GMT 2025 , Edited by admin on Wed Apr 02 07:26:31 GMT 2025
PRIMARY
FDA UNII
0SOY20O318
Created by admin on Wed Apr 02 07:26:31 GMT 2025 , Edited by admin on Wed Apr 02 07:26:31 GMT 2025
PRIMARY
NCI_THESAURUS
C207015
Created by admin on Wed Apr 02 07:26:31 GMT 2025 , Edited by admin on Wed Apr 02 07:26:31 GMT 2025
PRIMARY
From To
4_139 4_199
4_23 4_94
3_139 3_199
3_23 3_94
2_360 2_418
2_254 2_314
2_127 4_219
2_140 2_196
2_22 2_96
1_360 1_418
1_254 1_314
1_222 2_222
1_219 2_219
1_127 3_219
1_140 1_196
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_290
N 2_290
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_440] [2_440] C-TERMINUS LYSINE K3Z4F929H6
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL